Narazaki R, Watanabe H, Maruyama T, Suenaga A, Otagiri M
Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.
Arch Toxicol. 1998 Mar;72(4):203-6. doi: 10.1007/s002040050489.
To clarify the mechanism of cytotoxicity induced by captopril (Cp), interactions between tissue protein and Cp were studied by the enzyme-linked immunosorbent assay (ELISA) method. The amide-linked adducts [hemocyanin from keyhole limpet-Cp adduct (KLH-Cp) and poly-L-Lys-Cp adduct (pLys-Cp)] using carbodiimide, and a disulfide-linked adduct [ovalbumin-Cp adduct (OVA-Cp)] were prepared. To determine the formation of the protein-Cp adduct, rabbit antisera against KLH-Cp was employed. The immunoreactivities with pLys-Cp and OVA-Cp against anti KLH-Cp sera were elevated when compared with the unmodified protein. With the inhibition ELISA, this antisera was useful for detecting the Cp disulfide-linked conjugate. In kidney cytosol, a high level of immunoreactivity was observed. Plasma and liver cytosol reactivities were similar, and approximately 40% against kidney cytosol. Thus, a method for the detection of the Cp-protein adduct using ELISA has been established. Formation of the Cp-protein adduct was observed in rat plasma and in liver and kidney cytosol. These findings suggest the possibility that the formation of Cp-protein adduct is partially related to cytotoxicity in liver.
为阐明卡托普利(Cp)诱导细胞毒性的机制,采用酶联免疫吸附测定(ELISA)法研究了组织蛋白与Cp之间的相互作用。使用碳二亚胺制备了酰胺连接的加合物[钥孔血蓝蛋白-Cp加合物(KLH-Cp)和聚-L-赖氨酸-Cp加合物(pLys-Cp)],以及二硫键连接的加合物[卵清蛋白-Cp加合物(OVA-Cp)]。为确定蛋白-Cp加合物的形成,使用了抗KLH-Cp的兔抗血清。与未修饰的蛋白相比,pLys-Cp和OVA-Cp与抗KLH-Cp血清的免疫反应性有所提高。通过抑制ELISA,该抗血清可用于检测Cp二硫键连接的共轭物。在肾细胞溶质中观察到高水平的免疫反应性。血浆和肝细胞溶质的反应性相似,约为肾细胞溶质的40%。因此,已建立了一种使用ELISA检测Cp-蛋白加合物的方法。在大鼠血浆以及肝和肾细胞溶质中观察到了Cp-蛋白加合物的形成。这些发现表明Cp-蛋白加合物的形成可能部分与肝脏中的细胞毒性有关。